Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-01-19
1995-10-17
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544316, 544318, C07D23936, A61K 31505
Patent
active
054591457
ABSTRACT:
Antidepressant agents having the formula ##STR1## wherein R.sup.1 is a polycycloalkyl group; R.sup.2 is methyl or ethyl, X is O or NH; and Y comprises a 5- or 6-membered heterocyclic ring having one or two nitrogens; or fused bicyclic heterocyclic rings having a total of three nitrogen atoms, one in each ring and one angular nitrogen.
REFERENCES:
patent: 3636039 (1972-01-01), Gruenman et al.
patent: 3772288 (1973-11-01), Hardtmann et al.
patent: 3923833 (1975-12-01), Gruenman et al.
patent: 4006243 (1977-02-01), Strehlke et al.
patent: 4012495 (1977-03-01), Schmiechen et al.
patent: 4153713 (1979-05-01), Huth et al.
patent: 4193926 (1980-03-01), Schmiechen et al.
patent: 4261995 (1981-04-01), Weinhardt et al.
patent: 4308278 (1981-12-01), Schneider et al.
patent: 4322421 (1982-03-01), Weinhardt et al.
patent: 4567263 (1986-01-01), Eicken et al.
patent: 4582834 (1986-04-01), Stenzel
Saccomano Nicholas A.
Vinick Fredric J.
Benson Gregg C.
Brokke Mervin E.
Ford John M.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Calcium independent camp phosphodiesterase inhibitor antidepress does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium independent camp phosphodiesterase inhibitor antidepress, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium independent camp phosphodiesterase inhibitor antidepress will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597529